Elif Erdem1, Ibrahim Inan Harbiyeli2, Hazal Boral3, Macit Ilkit3, Meltem Yagmur1, Reha Ersoz1. 1. Department of Ophthalmology, School of Medicine, Cukurova University, 01330, Adana, Turkey. 2. Department of Ophthalmology, School of Medicine, Cukurova University, 01330, Adana, Turkey. inanharbiyeli@hotmail.com. 3. Division of Mycology, Department of Microbiology, School of Medicine, Cukurova University, Adana, Turkey.
Abstract
PURPOSE: To evaluate the efficiency of corneal collagen cross-linking (CXL) in addition to topical voriconazole in cases with mycotic keratitis. DESIGN: Retrospective case series in a tertiary university hospital. PARTICIPANTS: CXL was performed on 13 patients with mycotic keratitis who presented poor or no response to topical voriconazole treatment. METHODS: The clinical features, symptoms, treatment results and complications were recorded retrospectively. The corneal infection was graded according to the depth of infection into the stroma (from grade 1 to grade 3). The visual analogue scale was used to calculate the pain score before and 2 days after surgery. MAIN OUTCOME MEASURES: Grade of the corneal infection. RESULTS: Mean age of 13 patients (6 female and 7 male) was 42.4 ± 17.7 years (20-74 years). Fungus was demonstrated in culture (eight patients) or cytological examination (five patients). Seven of the 13 patients (54%) were healed with topical voriconazole and CXL adjuvant treatment in 26 ± 10 days (15-40 days). The remaining six patients did not respond to CXL treatment; they initially presented with higher grade ulcers. Pre- and post-operative pain score values were 8 ± 0.8 and 3.5 ± 1, respectively (p < 0.05). CONCLUSIONS: The current study suggests that adjunctive CXL treatment is effective in patients with small and superficial mycotic ulcers. These observations require further research by large randomized clinical trials.
PURPOSE: To evaluate the efficiency of corneal collagen cross-linking (CXL) in addition to topical voriconazole in cases with mycotic keratitis. DESIGN: Retrospective case series in a tertiary university hospital. PARTICIPANTS: CXL was performed on 13 patients with mycotic keratitis who presented poor or no response to topical voriconazole treatment. METHODS: The clinical features, symptoms, treatment results and complications were recorded retrospectively. The corneal infection was graded according to the depth of infection into the stroma (from grade 1 to grade 3). The visual analogue scale was used to calculate the pain score before and 2 days after surgery. MAIN OUTCOME MEASURES: Grade of the corneal infection. RESULTS: Mean age of 13 patients (6 female and 7 male) was 42.4 ± 17.7 years (20-74 years). Fungus was demonstrated in culture (eight patients) or cytological examination (five patients). Seven of the 13 patients (54%) were healed with topical voriconazole and CXL adjuvant treatment in 26 ± 10 days (15-40 days). The remaining six patients did not respond to CXL treatment; they initially presented with higher grade ulcers. Pre- and post-operative pain score values were 8 ± 0.8 and 3.5 ± 1, respectively (p < 0.05). CONCLUSIONS: The current study suggests that adjunctive CXL treatment is effective in patients with small and superficial mycotic ulcers. These observations require further research by large randomized clinical trials.
Authors: Marianne O Price; Lawrence R Tenkman; Amilia Schrier; Kelly M Fairchild; Stephen L Trokel; Francis W Price Journal: J Refract Surg Date: 2012-10 Impact factor: 3.573
Authors: Michael W Epperly; Peter Wipf; Renee Fisher; Darcy Franicola; Jan Beumer; Song Li; Rhonda M Brand; Louis D Falo; Geza Erdos; Joel S Greenberger Journal: In Vivo Date: 2018 Sep-Oct Impact factor: 2.155
Authors: M Roth; L Daas; A Renner-Wilde; N Cvetkova-Fischer; M Saeger; M Herwig-Carl; M Matthaei; A Fekete; V Kakkassery; G Walther; M von Lilienfeld-Toal; C Mertens; J Lenk; J Mehlan; C Fischer; M Fuest; S Kroll; W Bayoudh; A Viestenz; A Frings; C R MacKenzie; E M Messmer; B Seitz; O Kurzai; G Geerling Journal: Ophthalmologe Date: 2019-10 Impact factor: 1.059